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Intrauterine growth restriction (IUGR) is a pregnancy-related complication that is diagnosed 
more frequently due to improved antenatal surveillance with greater access to ultrasound 
equipment and training in ultrasound and it affects 3-5% of all pregnancies.  The addition of 
Doppler surveillance in high risk pregnancies has been found to decrease morbidity and 
mortality by 29%. 
 
Methods: 
This was a prospective cross-sectional descriptive study that took place at Chris Hani 
Baragwaneth Academic Hospital (CHBAH), a tertiary hospital in Soweto, Johannesburg, which 
conducts an average of 23,000 deliveries a year.  Study participants were collected over a 15 
month period and early-onset IUGR was defined as an abdominal circumference of less than 
the 5th percentile for a given gestation and diagnosed between 26+0 and 32+0 weeks of 
gestation.  Multivessel Doppler surveillance was performed to monitor these fetuses and 
optimally time delivery.  Pregnancy and neonatal outcomes were followed up. 
 
Results: 
A total of 60 women were included in the study.  Detailed data on outcomes was available for 
47 study participants.  Nineteen babies (40.6%) were discharged home after an average 
hospital stay of 62.6 days and 52.6% of these babies fulfilled the criteria for major morbidity.  
Twenty eight babies (59.4%) were mortalities, with 9 intrauterine fetal deaths, 2 medical 
terminations of pregnancy for maternal indications, 3 fresh still births, 9 early neonatal 
deaths, 3 late neonatal deaths and 2 infant deaths.  The average birth weight of babies that 
survived was 969g and the gestation was 29 weeks and 2 days, while in the group that 
demised, the average birth weight was 775.8g and the mean gestation was 28weeks and 4 
days. 
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All study participants had abnormalities on Doppler studies, with 38 of the 48 study 
participants having abnormalities in more than one vessel.  Abnormalities in the Ductus 




Babies born with IUGR at CHBAH tend to have severe, early onset IUGR at the time of 
diagnosis, with many compounding factors affecting their outcomes, the most important of 
which is their birth weight and the presence of an abnormal Ductus Venosus Doppler. 




Perinatal Outcomes in fetuses with early-onset fetal growth restriction 
at Chris Hani Baragwanath Academic Hospital (CHBAH) and accuracy of 
Doppler findings in predicting outcomes. 
1. INTRODUCTION  
Intrauterine growth restriction (IUGR) is a pregnancy-related complication that is associated 
with increased risk to the fetus and the risks are increased with a decrease in the fetal weight 
percentile (1).  The purpose of antenatal care is to offer the clinician the opportunity to 
intervene and improve outcomes in pregnancies where abnormalities or problems are found.  
Intrauterine growth restriction is one such complication that is diagnosed more and more 
frequently due to improved antenatal surveillance with greater access to ultrasound 
equipment and training in ultrasound and affects 3-5% of all pregnancies(2).  It is important 
to identify the growth restricted fetus as interventions may be instituted to minimise 
morbidity and mortality in those fetuses, as well as preventing iatrogenic complications such 
as unnecessary preterm delivery or operative delivery (1).  Lindqvist and Molin found a 7 fold 
increase risk of death in IUGR fetuses and determined that the identification of the condition 
prenatally could offer a 4 fold lowered risk of a poor outcome (3).  Queenon et al reported 
that risk of morbidity and mortality is increased to twenty fold when the fetal weight is less 
than the 3rd percentile for expected fetal weight (1).  The Barker Hypothesis states that IUGR 
is also associated with a greater risk of chronic conditions, such as Diabetes and 
hypertension, in adulthood (4). 
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2. LITERATURE REVIEW 
 
2.1 SCREENING FOR IUGR: 
 
2.1.1 History-taking  
2.1.1.1  Identifying the fetus at risk and its significance: 
It is pivotal that the attending obstetrician identifies the fetus at risk of developing 
intrauterine growth restriction in order to implement adequate monitoring.  Lindqvist et al 
reviewed 26968 pregnancies with IUGR, where 54% of these fetuses were identified 
antenatally, while the rest were not diagnosed until after delivery.  The study reported that 
IUGR babies not diagnosed antenatally had a 4-fold increased risk of serious perinatal 
morbidity, such as intracranial haemorrhage and cerebral palsy, when compared to the group 
that were diagnosed antenatally (3). Risk factors for IUGR should be sought when taking a 
detailed history from the mother.  A previous pregnancy complicated by IUGR is a significant 
risk factor as recurrence occurs in 20% of subsequent pregnancies (5).  The cause for the 
growth restriction may be maternal, fetal or placental and should be identified where 
possible.  Extrinsic causes, such as conditions resulting in utero-placental insufficiency, may 
carry a better prognosis as intervention may alter outcome or severity of disease progression, 
versus intrinsic causes, such as aneuploidy, where intervention cannot alter prognosis in that 
fetus and where the IUGR often develops very early in the pregnancy and is often more 
severe.   
 
2.1.1.2  Chronic Conditions: 
Maternal chronic conditions that affect the development of the placenta, such a 
preeclampsia (8-15.5% risk of developing IUGR) and Systemic Lupus Erythematosus (28.5% 
risk of IUGR in active disease) have been proven by a multitude of studies to cause IUGR 
secondary to placenta insufficiency (5).  The maternal comorbidity most strongly associated 
with poorer perinatal outcomes is hypertension.  Hypertensive conditions are associated with 
earlier onset of IUGR, earlier delivery, lower birth weights and higher rates of perinatal 
complications.  Besides congenitally and structurally abnormal infants, hypertension is the 
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most common cause of asymmetrical growth restriction, which in itself is associated with 
poor perinatal outcomes in 14% of pregnancies (versus 5% in appropriate-for-gestation 
infants) (6). Antiphospholipid Syndrome (APLS) is a common cause of pregnancy 
complications due to areas of placental thrombosis and the rate of IUGR approaches 30% (7).  
Pre-gestational diabetes is also a common condition amongst mothers attending antenatal 
care and the risk of IUGR needs to be recognised, either as a results of the vascular disease at 
placental level, or due to the congenital abnormalities that may develop in a fetus where the 
mother has poor glycaemic control (8).  Haeri et al found that the risk of IUGR increases 
proportionally with increasing end organ damage, specifically with worsening nephropathy 
and proliferative retinopathy (9).  Patients that are seen in antenatal clinic with chronic 
conditions such as these need to be referred from the first trimester if possible for 
ultrasound assessment and to establish baseline parameters to further assess growth serially 
through the pregnancy.   
 
2.1.1.3  Fetal Factors: 
Intrinsic fetal factors, such as aneuploidy and structural abnormalities, are strongly associated 
with IUGR and can be found in 10% to 40% of cases with congenital anomalies.  Karyotyping 
should be considered and offered, especially if IUGR is diagnosed early at less than 24 weeks 
gestation or if it is severe, with the estimated fetal weight being less than the 5th percentile 
for gestational age. (10)  IUGR is especially common in chromosomal aneuploidies with 
Trisomy 21 generally only causing a mild IUGR, but Trisomy 18 is associated with severe IUGR, 
especially depending on the severity of the abnormalities found (9).     
 
2.1.1.4 Infections: 
Congenital infections may be screened for and ultrasound features may be suggestive of 
certain congenital infections.  Cytomegalovirus has been found to cause cell destruction in 
the developing fetus, while Rubella causes vascular insufficiency.  Syphilis may also lead to 
IUGR.  These infections may be screened for in any pregnancy complicated by IUGR with 
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ultrasound evidence of infection or with the finding of normal Doppler studies which would 
exclude utero-placental insufficiency as a cause (8).  
 
2.1.1.5 Toxins: 
Mothers that smoke have been shown on average to have babies with birth weights of 458g 
less than the average birth weight for a given gestation (6).  Anticonvulsants and 
antineoplastic drugs, as well as illicit drugs, such as cocaine, are associated with growth-
restricted fetuses (9). 
 
2.1.2 Symphysis-fundal height: 
Examination of the symphysis-fundal height (SFH) can be used to screen for IUGR after taking 
a good history.   Measurement of the SFH was the first examination technique described as a 
screening tool and is measured from the superior edge of the pubis to the top of the fundus 
but can be inconsistent due to imprecise and varied measurements between health care 
providers (8).  Confounding factors, such as increased maternal adiposity, polyhydramnios 
and uterine fibroids must be considered when the SFH is not in keeping with the estimated 
gestational age (11).  It is however an easy and inexpensive technique that, when done 
correctly, can at least identify the fetus that requires further investigation to confirm or 
exclude IUGR.   
 
2.2 DIAGNOSIS OF IUGR: 
 
Ultrasound is considered the gold-standard for the diagnosis of IUGR.  It must be stressed 
that growth restriction when the gestation is unknown, can only be identified by serial 
ultrasounds (11).  The American College of Obstetricians and Gynaecologists suggests that if 
on ultrasound, the abdominal circumference is in keeping with the estimated gestational age, 
then the diagnosis of IUGR is highly unlikely (12). 
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2.2.1 The Definition of an IUGR Fetus: 
A growth restricted fetus is defined as a fetus that is failing to achieve its full genetic growth 
potential.  IUGR is most commonly diagnosed as an estimated fetal weight below the 10th 
centile for gestational age, although other definitions have been suggested (such as an 
estimated fetal weight below the 5th and 3rd percentile and an abdominal circumference 
below the 5th and 3rd percentile) (12) .  The abdominal circumference has been found be the 
first parameter that lags in fetal growth restriction due to decreased glucose storage in the 
liver secondary to decreased hepatic blood flow, while the transcerebellar diameter is 
unchanged, even in severe cases of IUGR (1).  Many definitions have blurred the lines 
between the small for gestation fetus, (or commonly called constitutionally small), and the 
fetus that is small for gestation due to a pathological process.  A constitutionally small fetus is 
not necessarily at risk for a poorer outcome and as many as 70% of fetuses below the 10th 
centile fall into this group (6).  The fetuses often have parents that are smaller in stature or 
may be from a population group that typically is more petite in build.  For this reason, 
population- specific growth charts may be used to assess growth in the developing fetus (3).  
Buck et al suggests that a fetus with a normal growth trajectory over serial ultrasounds and 
who has normal Dopplers and amniotic fluid index, is more likely to be a constitutionally 
small fetus than a growth restricted fetus due to an underlying pathology (13).   
 
2.2.2 Accurate Gestational Dating: 
Accurate dating of a pregnancy is thus very important in identifying the growth restricted 
fetus, as an accurate gestational age is needed to identify an abnormal growth trajectory.  
Various clinical and ultrasound methods are used to attempt to accurately date a pregnancy. 
 
2.2.2.1 Clinical Methods: 
The first and most commonly used clinical method is taking a history and determining the 
date of the last normal menstrual period (LNMP).  Naegele’s Rule, which involves using the 
date of the last menstrual period, subtracting three months and then adding seven days, is 
used to determine the expected date of delivery (EDD) the following year.  This method is 
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compromised if a woman does not have a regular 28 day cycle and may be limited by the 
variation in the fertile window period, as well as in the woman who is unsure of her last 
menstrual period.  Clinical examination of the size of the uterus can also be used as the 
uterus becomes palpable above the pelvic brim from 12 weeks of gestation but is not very 
accurate.  (14) 
 
2.2.2.2 Ultrasound Methods:   
Ideally, dating by ultrasound should be done as early in the pregnancy as possible and in 
conjunction with the last menstrual period if the woman is sure of her dates.  Nielson et al 
reviewed 34249 pregnancies dated with LNMP and then LNMP with early ultrasound and 
found that a large majority of women delivered within 7 days of the EDD given by early 
ultrasound versus using the LNMP in isolation (15).   
 
a)  First trimester dating: 
Different parameters on ultrasound have been suggested to use in dating a pregnancy, 
depending on the trimester of the pregnancy.  The following can be used in the first 
trimester: 
The gestational sac (GS) is the first sign of pregnancy visualised within the uterus from four 
and a half to five weeks of gestation.  The mean sac diameter is most commonly used as a 
dating tool and has been found to have a small margin of error up to only five days.  Studies 
have shown that it is only accurate up to a GS diameter of 14 mm and once the fetus is 
visible, a crown-rump length should be used instead.  (16) 
The yolk sac (YS) is the first structure visualised within the gestational sac but is not an 
accurate method to use (16). 
The crown-rump length is best done before 14 weeks of gestation and has a margin of error 
of about 3-5 days (1).  It is measured as a straight line from the cephalic pole to the rump of 
the fetus.  Papageorghiou et al found it to be accurate up to a measurement of 84mm, after 
which other biometric parameters should be used. (17) 
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b) Ultrasound dating after the first trimester: 
Fetal biometry is used after the first trimester, using namely the fetal biparietal diameter 
(BPD), the head circumference (HC), the abdominal circumference (AC) and the femur length 
(FL).  The measurements are combined using the Hadlock Formula to derive a gestational age 
that has an accuracy of 7 to 10 days from 14-20 weeks.  After the 26th week of gestation, 
biometry may lead to a margin of error of up to four and a half weeks.  (18) 
 
The BPD is considered a highly reproducible measurement and is most commonly measured 
from the outer edge of the one side of the skull to the inner edge of the opposite side of the 
skull at either the trans-cerebellar or trans-thalamic planes in an axial view.  Oligohydramnios 
may result in dolicocephaly which affects the accuracy of the BPD measurement. (19) 
 
The abdominal circumference is measured at the level of the union of the right and left portal 
veins, in a plane where the stomach bubble and lower ribs are also visualised.  The abdominal 
circumference is altered by oligohydramnios and changes in fetal movement.  It has been 
found to have a margin of error of up to four weeks gestation if measured in the third 
trimester. (19) 
 
Femur length is often used in later gestations to date a pregnancy as it has the smallest 
margin of error of two weeks in the third trimester and the actual measurement is largely 
uncompromised by surrounding factors such as liquor volume.  Abnormal lengths are found 
in skeletal dysplasia and early-onset IUGR. (19) 
 
c) Transcerebellar Diameter: 
The transcerebellar diameter (TCD) had been recommended to be used as one of the 
definitive ultrasound measures of dating a pregnancy later in gestation and is largely 
unchanged in even severe cases of IUGR (1).  It is located in the posterior fossa of the fetal 
skull and is measured as the maximum diameter across the cerebellum in an axial plane 
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where both the cisterna magna and the septum pellucidum can be seen.  The posterior fossa 
is relatively protected to external pressures and the cerebellum is not affected by alterations 
in fetal growth.  (20)    The TCD has been found to correlate in millimetres (mm) with the 
equivalent gestational age in mm up to 22mm (19).  
 
When analysing 50 singleton pregnancies affected by IUGR, Bhimarao compared the ratios of 
TCD:AC to HC:AC and found that all other parameters had a margin of error in terms of dating 
the pregnancies of greater than three weeks, where the TCD was much more accurate.  The 
TCD correlated by three days in 97.5% of second trimester pregnancies and in 93.3% in third 
trimester pregnancies (20).   
 
2.3 THE PATHOPHYSIOLOGY OF IUGR: 
 
It is essential to understand the pathophysiology of IUGR and the adaptions in the fetus, in 
order to understand the changes that can be seen on ultrasound.  As mentioned, IUGR is 
most commonly diagnosed on ultrasound when the abdominal circumference or the 
estimated fetal weight is less than the 10th percentile for gestational age (12).  The fetus 
experiences higher pressures at the materno-placental interface and hypoxemia then 
stimulates peripheral arterial chemoreceptors in the fetus.  The fetus adapts to this 
environment by increasing blood flow to essential organs, namely the brain, heart and 
adrenals, while sacrificing blood flow to other organs, such as the kidneys and liver (11).  The 
biometry (biparietal diameter, abdominal circumference and femur length) will all be less 
than what is expected for a given gestational age.  Decreased flow to the liver results in 
decreased glycogen storage in the fetal liver, often resulting in an abdominal circumference 
that is more obviously lagging than the other measurements (1).   
 
Another result of this adaption may be oligohydramnios, which is defined as a single deepest 
pool of amniotic fluid measuring less than or equal to 2cm or an amniotic fluid index 
measuring less than or equal to 8cm (21).  Oligohydramnios results from decreased renal 
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blood flow secondary to shunting of oxygenated blood to other vital organs and hence 
decreased urine production, but also from a central activation of vasopressin in the fetal 
brain as a result of the stress response, leading to decreased urine output (11).  The current 
literature is unclear on how important the finding of oligohydramnios is.  A study done by 
Chauhan et al found that only 10% of IUGR pregnancies are complicated by oligohydramnios, 
but that these pregnancies have a greater perinatal mortality rate, which increases the 
smaller the smallest pocket of amniotic fluid.  The study also showed that pregnancies 
complicated by oligohydramnios are twice as more likely to need an emergency caesarean 
section for a non-reassuring heart pattern during labour on fetal heart monitoring (22).  The 
American College of Obstetrics and Gynaecology states that the amniotic fluid index is of 
great prognostic value in IUGR, whereas the Green-top guidelines published by the Royal 
College of Obstetricians and Gynaecologists states that it is of minimal value in IUGR (12, 23).  
 
2.4 FETAL SURVEILLANCE: 
 
Once IUGR has been diagnosed, there are recommended methods to monitor these fetuses 
and optimally time delivery.  Protocols for monitoring will depend on institutes but may 
include two of three methods, namely the Biophysical profile, non-stress test (NST) and 
multi-vessel Doppler surveillance.  In addition, basic fetal monitoring by the mother by fetal 
kick movements can also help detect a fetus at risk, as a hypoxic fetus with move less to 
conserve energy (11).   
 
2.4.1 The Non-Stress Test: 
The non-stress test (NST) is an investigation that monitors the fetal heart pattern over a 
period of time.  It is used in practice both antenatally and during labour.  The NICE criteria, 
published in 2014, have become the gold standard for interpreting a NST.   A reassuring trace 
is defined as a fetal heart baseline rate between 100 and 160 beats/minute, with baseline 
variability of at least 5 beats/ minute and no decelerations in the fetal heart rate.  Abnormal 
traces are defined as a baseline fetal heart rate above 180 beats/minute or less than 100 
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beats/minute, a drop in baseline by more than 60 beats/minute for greater than 60 seconds, 
late decelerations for more than 30 minutes, despite instituting intra-partum resuscitation, or 
a single prolonged deceleration for greater than 3 minutes. (24)  In IUGR, a decrease in 
baseline variability has been linked to acidemia in the compromised fetus, whereas 
decelerations are considered a late sign of serious decompensation in the fetus (11). 
 
2.4.2 The Biophysical Profile: 
The biophysical profile (BPP) is a non-invasive test done to monitor the well-being of a fetus 
at risk.  It has 5 components, 4 of which are ultrasound components (namely looking at 
distinct fetal movements, fetal tone, fetal breathing and the amniotic fluid volume) and the 
last is a non-stress test (NST) component (25).  The assessment is scored as 0 or 2 for each 
component and a total score out of 10 is given.  A score of 8 is considered normal.  It is 
assumed that with a normal BPP, the regulatory centres in the brain of the fetus are intact 
(26).  It is important to note that there are factors that may alter the BPP and must be kept in 
mind when interpreting the results.  Fetal sleep may lead to an abnormal BPP but no more 
than two parameters will be abnormal and if repeated after thirty minutes, those parameters 
should be normal again.  The administration of antenatal steroids leads to an abnormal BPP, 
as well as decreased variability in fetal heart rate on NST.  These changes return to normal 
within 4 days of administration of the drug. (27)   
 
2.4.3 Doppler Studies: 
Doppler studies of the arterial and venous system of the fetus have been used in the 
screening, diagnosis and monitoring of the IUGR fetus.  Doppler studies may offer 
information to predict deterioration in fetal condition, and therefore, an opportunity to 
intervene.  It can also prevent unnecessary admissions for the mother, as well as prevent 
unnecessary and early delivery of an IUGR fetus (1).  If during routine ultrasounds to assess 
growth in high risk pregnancies, low resistance waveforms are seen, it is a good predictor 
that there has been adequate trophoblastic invasion into the spiral arterioles during the 
development of the placenta and thus a lower risk of placental insufficiency (11).     
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a) The Umbilical Artery 
The umbilical artery (UA) Doppler is often the first to be measured.  In a normal pregnancy, 
the fetus receives blood flow through the umbilical artery throughout the fetal cardiac cycle, 
namely during both the systolic and diastolic phases, but with advancing placental 
insufficiency and rising resistance in the umbilical artery, the flow may become absent or 
reversed during the diastolic phase of the cardiac cycle.  Once there is established reversed 
end diastolic flow (REDF), it means that greater than 70% of the placental bed is not 
functional and during diastole, due to very high pressures in the placenta, backflow from the 
fetus is observed.  The Society for Maternal-Fetal Medicine recommends measuring the UA 
Doppler near the abdominal wall insertion point when the fetus is not breathing and when 
there is a uniform waveform for accurate measurements, avoiding measuring near the 
placental insertion point at there is higher flow and higher pressures at that point.  Studies 
have shown that both absent and reversed diastolic flow are more common in fetuses with 
IUGR with an estimated fetal weight of less than the 3rd percentile and where 
oligohydramnios is diagnosed. (21) 
 
b) The Middle Cerebral Artery 
The middle cerebral artery (MCA) is measured in a transverse plane of the fetal head, at the 
proximal end of the vessel near the Circle of Willis.  Vasodilation and increased flow in the 
cerebral arteries is an indicator of ‘brain-sparing’, which is part of the fetal adaption to 
counteract a hypoxic environment (21).  Various other studies have used the cerebro-
placental ratio (CPR), which is the pulsatility index of the MCA divided by the pulsatility index 
of the UA, to prove brain-sparing in a compromised fetus (21).  Flood et al studied 881 
fetuses with IUGR and showed that a CPR of less than one is associated with poorer neonatal 
outcomes in IUGR (28).  De Vore et al found the CPR a more valuable predictor of morbidity 
than a biophysical profile (29). 
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c) The Ductus Venosus 
The Ductus venosus (DV) is the first and commonly, the only venous Doppler performed.  It is 
best measured in a sagittal or transverse section of the abdomen, at the level of the 
diaphragm (21).  The DV have been said to be indicative of the cardiac effects of placental 
dysfunction (30).  It has a triphasic waveform.  The first peak correlates with ventricular 
systole, the second with passive filling of the ventricle.  The nadir between the two peaks, 
called the á-wave, represents atrial contraction during late diastole.  It is changes in this a-
wave which are most indicative of problems in a compromised fetus.  A hypoxic environment 
leads to compensatory changes in the fetus by venous shunting across the ductus to try 
increase the blood volume returned to the heart, bypassing the liver and thus compensating 
by increasing the right ventricular afterload, and in turn maintaining left ventricular output as 
blood shunted across the foramen ovale is increased (21). With worsening hypoxia, the 
accumulation of lactic acid leads to myocardial dysfunction and failure of this compensatory 
mechanism, which is evidenced by changes in the a-wave, namely becoming decreased, 
absent or eventually reversed (31).  
 
2.4.3.1 The significance of Dopplers in IUGR: 
In high risk pregnancies, the addition of Doppler surveillance has been found to decrease 
morbidity and mortality by 29% (32).  Crimmins et al retrospectively compared Doppler 
findings between live and stillborn growth-restricted fetuses, as well as changes in the 
biophysical profile in relation to fetal deterioration or death.  There were a total of 47 
stillbirths and 39 perinatal deaths of the 987 fetuses classified as IUGR.  Majority of the 
stillbirths (79%) occurred before 34 weeks of gestation and all of these fetuses had severe 
IUGR, classified as an EFW below the 1st percentile for gestational age, which may indicate a 
greater degree of placenta dysfunction in early-onset IUGR.  When analysing the biophysical 
profile, the 5 criteria were assessed and a score was given.  In the stillbirths that occurred 
before 34 weeks of gestation, a parallel escalation in the umbilical artery and ductus venosus 
Doppler values was seen which preceded a deterioration in the biophysical profile, which 
could then be used to anticipate a stillbirth in this group.  Absent end diastolic flow (AEDF) in 
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the Umbilical Artery had the shortest interval between detection and stillbirth and was seen 
as an indicator for severe compromise.  (33) 
 
A staging system for IUGR is described in the literature, based on the Doppler abnormality 
found.  Fetuses classified as Stage I have an abnormal pulsatility index in either the UA or the 
MCA.  Stage II will have an abnormal peak systolic velocity in the MCA, a raised PI in the DV, 
absent or reversed flow in the UA or pulsations in the umbilical vein.  Stage III is the most 
severe and is diagnosed when there is reversed flow in the Ductus Venosus, reversed flow in 
the umbilical vein or tricuspid regurgitation in the fetus.  A study conducted by Mari et al 
retrospectively studied 74 IUGR fetuses delivered at or below 32 weeks of gestation and 
analysed their outcomes according the Doppler findings and staging as described above.  The 
study found that babies classified as Stage I tended to have a later gestational age at delivery 
and that there was a progressive decline in birth weights with an increase in severity of 
Doppler findings and hence staging.  Poorer outcomes also increased with advancing staging. 
(34) 
 
2.4.3.2 The Progression of Doppler Changes: 
Bashat has published multiple works on the progression of Doppler findings in the IUGR fetus.  
Many studies have suggested and it has been accepted that there is often a typical or 
predictable progression of Doppler findings reflecting compensatory changes in the fetus that 
allows easier monitoring and understanding of the degree of compromise in each IUGR fetus.  
The first change is a decrease in flow in the umbilical vein, which the fetus detects and then 
responds to by decreasing blood flow to non-vital organs.  The resistance then increases in 
the umbilical artery when an average of 30% of the placental bed in non-functional, reflected 
by an increase in the pulsatility index (PI) of the umbilical artery.  As the fetus tries to 
maintain blood perfusion in the brain, vasodilation of the middle cerebral artery is seen by a 
decrease in the pulsatility index of the MCA.  Flow in the umbilical artery becomes further 
compromised and absent or reversed end diastolic flow is seen on Doppler study of the UA.  
The fetus becomes more and more hypoxic and cardiac decompensation is then reflected by 
26 | P a g e  
 
an absent or reversed a-wave in the ductus venosus.  The deterioration in the BPP and NST 
will then follow.  (31, 35, 36)  
 
Turan et al performed a prospective observational study that was published in 2008 including 
104 patients and one aspect that was analysed was the time to progress between each 
Doppler change and then the duration of each abnormal Doppler finding until delivery.  This 
study was important as it challenged a preconceived notion that the progression of Dopplers 
tends to be predictable.  The study showed that where IUGR is complicated by Doppler 
changes only after 30 weeks of gestation and if there is no progression from an increased 
pulsatility index in the umbilical artery within the first 14 days, then there is unlikely to be 
significant Doppler changes or progression.  Only 67% of the pregnancies studied did follow 
the typical progression described above.  (30) 
 
2.5 MANAGEMENT OF IUGR: 
 
One of the most difficult dilemmas faced in managing a pregnancy with IUGR is the optimal 
time to deliver the fetus.  The difficult balance between intervening before severe 
compromise and death occurs, and preventing iatrogenic complications of prematurity, must 
be considered.  The GRIT Study (Growth Restriction Intervention Trial) is one of the few 
randomized controlled trials on IUGR and analysed the ideal time to deliver the compromised 
fetus with IUGR and the perinatal outcomes associated in 587 fetuses.  Delivery was the 
intervention and was either immediate (within 48 hours of diagnosis or completing steroids if 
less than 34 weeks gestation) or delayed until the clinician found a firm indication to deliver 
the fetus. The umbilical artery Doppler was the indices studied and was recorded as 
increased, absent or reversed.  The study concluded that delaying delivery of a compromised 
fetus with IUGR may increase the number of stillbirths (9 vs 2), but immediate delivery 
increases the complications of preterm delivery such as mechanical ventilation and neonatal 
deaths (23 vs 12).  The average time to delivery in the delayed group was 4.9 days.  (37)  A 
follow-up paper was then published detailing long-term outcomes of the GRIT Study, which 
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showed that at two years of age, children showed no significant difference in cognition, 
language, motor performance and behaviour between the two groups (38).   
 
The findings of the GRIT Study were not supported by the DIGITAT randomized control trial.  
Induction of labour in pregnancies complicated by IUGR beyond 36 weeks gestation was 
compared to expectant management.  The admissions to Intensive Care was similar in both 
groups, but the admissions to intermediate care were higher in the induction group.  The 
neonatal outcomes were analysed using a MAIN (morbidity assessment index for new-borns) 
Score, which analyses multiple clinical and laboratory findings (such as cord pH, urine output, 
respiratory rate, thrombocytopenia, development of seizures to name a few, both in the first 
24 hours of life and in the seven days after birth), to determine morbidity in the first week of 
a neonate’s life (39).  The increase in admissions to intermediate care was found to be 
insignificant.  The significant difference between the two studies is the average gestational 
age of the fetuses studied and the GRIT study is most relevant to this study as it too focuses 
on early-onset IUGR.  (40)  
 
A prospective study published by the American College of Obstetricians and Gynaecologists 
(ACOG) assessed 145 IUGR pregnancies and monitoring of fetal well-being using NST, BPP 
and Dopplers.  The study showed that most commonly delivery was indicated when the BPP 
score was less than or equal to 4 or when there were significant abnormalities on NST.  One 
very significant finding in this study was that fetuses with an abnormal ductus venosus only 
had changes on NST and BPP on average within 7 days, indicating a possible window to delay 
delivery and every week in utero can decrease morbidity by 50% (41).  Turan et al published a 
study on the duration of abnormal ductus venosus and found that an abnormal ductus 
cannot be prolonged for greater than one week, as long as the NST remains reactive in that 
time.  Of 177 IUGR fetuses, 18 were stillbirths and 34 suffered major morbidity.  The average 
birth weight of the fetuses with major morbidity was 635g, adding severe prematurity as a 
compounding factor in the poor outcomes of these fetuses.  Intrauterine fetal death 
developed within 6 days on average and an absent or reversed a-wave was far more common 
in the stillbirth group (versus just a raised PI). (42)   
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In terms of management guidelines, there are various important bodies to consult.  The 
Society for Maternal-Fetal Medicine publications committee suggests conservative 
management until 34 weeks gestation in IUGR fetuses with absent end-diastolic flow in the 
umbilical artery and conservative management up until 32 weeks gestation where reverse 
diastolic flow is found, as long as monitoring with NST (non-stress test) remains reassuring, 
after which delivery should be planned.  Dopplers should be done every 1-2 weeks, but if 
normal, can then be done less regularly (21) .   
 
The Royal College Guidelines on management of a small-for-gestation fetus suggests that a 
high umbilical artery PI>95th centile with positive end diastolic flows requires twice weekly 
follow up ultrasounds and if the flow is absent or reduced, daily follow up ultrasounds.  This 
monitoring should be paired with daily NST’s, where the beat-to-beat variability has been 
shown to be the most significant factor to observe.  These guidelines do not recommend 
Biophysical profiles as a monitoring tool.  The guideline further recommends that in preterm 
infants <34 weeks gestation, abnormalities in the Ductus Venosus is an indicator to deliver, 
not the MCA, and in fetuses above 34 weeks of gestation, redistribution in the MCA is an 
indication that the fetus must be delivered, as they have the strongest predictive value for 
poor outcome.  It recommends that in fetuses with absent or reversed end-diastolic flow in 
the umbilical artery, delivery should be at 32 weeks gestation once steroids are complete, or 
before that if the Ductus Venosus becomes abnormal. (23)  
 
ACOG recommends delivery from 34 weeks onwards if abnormalities are seen in the 
umbilical artery, or if other risk factors such as oligohydramnios or maternal comorbidities 
coexist.  ACOG also notes to use magnesium sulphate for neuroprotection if delivery is 
anticipated before 32 weeks of gestation (12).  All three above guidelines highlight the fact 
that IUGR as an isolated finding is not an indication for caesarean section and each case 
should be individualised according to fetal and maternal indications.   
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2.6 PERINATAL MORBIDITY AND MORTALITY: 
 
IUGR leads to multiple risks to the fetus, both while intrauterine and in the postnatal period.  
IUGR has been found to lead to a 7-fold increased risk of death, which increases to a 35.8-
fold increased risk of death in the fetus who is less than the 3rd percentile for fetal weight at a 
given gestation (3).  The newborn infant is at an increased risk for complications such as 
hypothermia, hypoglycaemia and sepsis, to name a few (12). 
 
The PORTO Trial (Prospective Observational Trial to Optimize Paediatric Health in Intrauterine 
Growth Restriction) was a large prospective trial conducted in Ireland that included more 
than 1100 singleton pregnancies diagnosed with IUGR (defined as an EFW or AC of <10th 
centile).  Adverse perinatal outcomes were defined as intraventricular haemorrhage, 
periventricular leukomalacia, necrotizing enterocolitis, bronchopulmonary dysplasia, 
neonatal sepsis and death.  1 in 20 babies suffered adverse outcomes overall, with an EFW 
<3rd centile being the most statistically significant and all 8 deaths (4 stillbirths and 4 neonatal 
deaths) occurred in this group.  An abnormal umbilical artery Doppler (specifically absent or 
reversed flow) had the strongest association with poor outcomes.  An estimated fetal weight 
<5th percentile had a mortality rate of 5, 3%, that increased to 16, 7% when an abnormal 
Doppler was found.  The morbidity rate when the EFW <3rd percentile was 6, 2%, but that 
was increased to a significant 13% when the fetuses also had abnormal Dopplers.  The PORTO 
Study therefore suggested that an EFW <10th centile with an abnormal umbilical artery 
Doppler or an EFW <3rd centile is a more adequate definition of IUGR than EFW <10th centile 
alone.  The PORTO study found that oligohydramnios was only a significant finding when 
compounded by an estimated fetal weight of below the third centile.  A low cerebro-
placental ratio of <1 was associated with 18% of adverse neonatal outcomes.  The PORTO 
study also saw a ‘typical’ pattern of progression of Doppler changes in 46% of the IUGR 
fetuses studied.  (43) 
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Lees et al published the largest prospective randomized control study to date in 2013.  The 
TRUFFLE Study (Trial of Randomized Umbilical and Fetal Flow in Europe) aimed to describe 
perinatal morbidity and mortality in early-onset IUGR (26-32weeks gestation) in 503 
pregnancies, in 20 European perinatal centres over a 5 year period, as well as the Doppler 
findings in the pregnancies.  The intervention was delivery of the fetus and there were three 
randomization groups according to indication to deliver, namely reduced short-term 
variability on NST, a Ductus venosus PI that was greater than the 95th percentile or late 
changes in the Ductus (described as absent or reversal of the a-wave).  Defining IUGR as an 
EFW <10th centile with an umbilical artery Doppler pulsatility index (PI) >95th percentile, 
overall 2.4% of fetuses died in-utero and a further 5.5% of the 491 livebirths died in the 
neonatal period.  Of the deaths in the neonatal period, 18% died as a result of sepsis, while 
10% died as a result of pulmonary dysplasia. (37)   
 
The average gestational age at delivery was just under 31 weeks and 97% of the 490 live 
births were delivered by caesarean section.  Severe mortality was described similarly to in the 
PORTO Trial above as bronchopulmonary dysplasia, severe cerebral germinal matrix 
haemorrhage, proven neonatal sepsis, periventricular leukomalacia or necrotizing 
enterocolitis and 24% of live- born fetuses were affected.  31% of fetuses met the criteria for 
severe morbidity or mortality.  Poorer outcomes were more strongly associated with earlier 
gestations, lower birthweights and lower APGARS at the time of delivery.  Maternal 
hypertension was found to be a significant risk factor for developing early onset IUGR, with 
73% of mothers being hypertensive but it also showed that hypertension was the only 
maternal comorbidity proven as an independent risk factor for poorer neonatal outcomes.  
The median time between abnormalities in the Umbilical Artery and the development of fetal 
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3.  PROBLEM STATEMENT: 
 
Intrauterine growth restriction has shown to be a complication associated with preterm 
labour and poorer perinatal outcomes in many overseas trials, but its burden has not been 
quantified in our resource-restricted setting.  IUGR is diagnosed more commonly at Chris 
Hani Baragwaneth Academic Hospital (CHBAH) as more patients gain access to ultrasound 
during pregnancy and a dedicated Fetal Medicine Unit is readily available to assess 
complicated cases.  The aim is to study the outcomes in these babies, as well as the Doppler 
findings to determine the predictive value for short-term prognosis for abnormal Doppler 
findings in IUGR at CHBAH. Findings from the study are pivotal in aiding with the counselling 
of parents with IUGR babies about expected outcomes, specifically in a South African setting. 
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4. OBJECTIVES FOR THE STUDY 
 
a. To determine the maternal comorbidities associated with IUGR fetuses 
b. Determine the perinatal outcomes in fetuses affected by early-onset 
intrauterine growth restriction at CHBAH  
c. Assess the prognostic value of various Doppler findings (PI and changes in 
waveform) to predict perinatal outcome 
i. Umbilical artery (UA) Doppler 
ii. Middle cerebral artery (MCA) Doppler 
iii. Ductus venosus (DV) 
 
  






The study took place at the Fetal Medicine Department at CHBAH, a tertiary academic 
hospital in Soweto, Johannesburg which performs approximately 23 000 deliveries a year.  
The Maternity Sonar department performed 17838 ultrasounds in 2014, 2430 of which were 
done by the Fetal Medicine Department (44).  Patients requiring specialist sonars are 
identified by referral from the maternity sonographers and registrars in the obstetrics and 
gynaecology department, as well as from other referral hospitals in surrounding areas.  The 
fetal medicine team then continues follow up with the patients that are identified as high 
risk, needing further sonar monitoring. 
 
5.2 STUDY DESIGN: 
 
The study was a prospective cross-sectional descriptive study. 
 
5.3 SAMPLE SIZE: 
 
Data was collected over a fifteen month period from May 2015 to July 2016 in order to 
achieve a pool of 60 patients. 
 
5.4 STUDY POPULATION: 
 
The study invited all pregnant patients found to have early-onset IUGR to participate.  Early-
onset IUGR was defined as an abdominal circumference less than the 5th percentile for a 
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given gestational age and diagnosed between 26 weeks and 0 days and 32 weeks and 0 days 




Sonar machines used were Medison Accuvix V20 and an Aloka Alpha Prosound 10 machines.  
The growth charts, Doppler charts and estimated fetal growth chart are standardised on the 
View Point Database version 4.00.05.  The specific growth chart used for estimated fetal 
weight is found in Appendix B.  All ultrasounds were performed by fetal medicine 




The Fetal Medicine team, comprising of Fetal Medicine Specialists and fellows in Fetal 
Medicine, enrolled patients into the study at the initial consult when IUGR was diagnosed and 
after informed consent was obtained.  IUGR was defined as per department protocol as an 
abdominal circumference below the 5th percentile for a given gestational age.  At the time of 
diagnosing IUGR, all patients had level three anatomical assessments of the fetus.  
Pregnancies were dated by early sonars (done before 20 weeks of gestation, preferably by 
crown-rump length done from 11-13 weeks of gestation) or if greater than 20 weeks 
gestation, by last normal menstrual period (LNMP) if sure of dates.  If the mothers were 
unsure of dates or if the pregnancy was an advanced gestation, the pregnancies were dated 
by transcerebellar diameter (TCD).   
 
Inclusion criteria: 
 Women over 18 years of age who have given informed consent 
 Singleton pregnancy 
 Between 26 weeks and 0 days and 32 weeks and 0 days gestation 
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 Diagnosed with IUGR (defined as an abdominal circumference below 
the 5th percentile for a given gestational age) 
 Utero-placental insufficiency evidenced by abnormal fetal Doppler 
studies.   
 
Exclusion criteria: 
 Multiple pregnancies 
 Chromosomal abnormalities confirmed on invasive genetic testing  
 Structural /congenital abnormalities in the fetus (these included all 
structural abnormalities that may impact on morbidity and mortality) 
 Patients who chose not to participate 
 Fetuses with ultrasound evidence of intrauterine congenital infection 
or proven congenital infection on an antenatal TORCH screen or post-
natal assessment 
 
Once enrolled in the study, bed letters and antenatal cards were marked with a specific 
sticker to inform and indicate to all staff members that the patient was a trial participant.  
These stickers included the researcher’s contact details so the study participants could make 
contact if necessary.  Repeat sonars were documented until the timing of delivery and 
reassessments were individualised at the discretion of the Fetal Medicine consultant 
depending on the degree of abnormality found and gestational age.  Each patient had a 
printed report at each review and it was requested that the researcher be informed each 
time the patient was admitted and at the time of delivery.  Poster notifications throughout 
the department and announcements at department academic meetings were used to inform 
medical staff about the study 
 
Once IUGR was diagnosed, multi-vessel Doppler surveillance was initiated combined with 
NST’s.  The department specifically performed the umbilical artery (UA) Doppler, the middle 
cerebral artery Doppler (MCA) and the ductus venosus (DV) Dopplers as a standard practice 
36 | P a g e  
 
for baseline Doppler studies.  The Dopplers were performed according to the 
recommendations prescribed by the Society of Fetal Medicine.  The UA Doppler was taken 
from a section of cord that was not right near the placental end, as this may reflect greater 
pressure transmitted from the placental circulation.  The MCA was examined in a transverse 
section of the fetal head at the base of the fetal skull, at 0-degree angle of incidence.  The DV 
was sampled in a transverse section of the fetus at the level of the fetal diaphragm, as it 
branches from the umbilical vein. (21) 
Abnormal Dopplers were defined as: 
 Umbilical artery Doppler with a PI >95th percentile ±absent or reversed end 
diastolic flow 
 MCA Doppler PI<5th percentile which indicates redistribution 
 Ductus Venosus Doppler that has a PI >95th percentile or changes in the a-
wave (absent or reversed) 
 
5.7 DATA COLLECTION: 
 
Data was collected prospectively using data sheets (See Appendix A) and completed for all 
participating patients.  No identifying data was recorded on the sheet and an individual study 
number was assigned to each participant.  Maternal, fetal and neonatal data were recorded. 
 
5.8 SURVEILLENCE AND DEFINITIVE MANAGEMENT: 
 
The researcher travelled to CHBAH on a weekly basis and the babies were followed up 
antenatally, post-delivery and until babies were discharged from hospital.  The researcher 
collected data sheets from the Fetal Medicine department and met with the patients in the 
ward if they were in patients or contacted them telephonically to introduce herself and 
provide detailed information about the study.   
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 Existing department surveillance and management protocols for IUGR babies were adhered 
to for the study and algorithm below summarises the surveillance protocol followed by the 
department.   
 
Maternal indication for delivery always took precedence over fetal indication but only with 
maternal informed consent.  
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NST indication for delivery was any pathological trace, as diagnosed at the discretion of the 
attending obstetrician at the time.  The protocol for NST interpretation at CHBAH are based 
on the NICE criteria.  A reassuring trace was defined as a fetal heart baseline rate between 
100 and 160 beats/minute, with baseline variability of at least 5 beats/ minute and no 
decelerations in the fetal heart rate.  Abnormal traces are defined as a baseline above 180 
beats/minute or less than 100 beats/minute, a drop in baseline by more than 60 
beats/minute for greater than 60 seconds, late decelerations for more than 30 minutes, 
despite instituting intra-partum resuscitation, or a single prolonged deceleration for greater 
than 3 minutes. (11) 
 
The department offered all patients diagnosed with IUGR in the pregnancy counselling by a 
multidisciplinary team comprising Fetal Medicine specialists, obstetricians and neonatologist. 
All patients with fetuses with borderline weights of 900g or less were counselled by this team 
regarding possible implications of delivering the fetus at these low birth weights and a 
possible prolonged hospital stay.  They were also referred to the social worker for supportive 
counselling. 
 
Delivery information was obtained from the caesarean section registers in labour ward 
theatre or from the labour ward registers if the patients were delivered vaginally.  Both 
labour ward and caesarean section theatre had two registers.  One documented maternal 
admissions such as the date of delivery and indication for delivery and a second documented 
the babies’ weights, apgars and admission ward if admitted. 
 
5.9 PERINATAL FOLLOW UP: 
 
Perinatal outcomes that were assessed included death (in-utero, early neonatal or late 
neonatal), need for mechanical ventilation and ICU admissions, as well as one or more severe 
perinatal morbidities.   
Severe perinatal morbidity included:  
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 Intra-ventricular haemorrhage defined as haemorrhage associated with 
dilatation of the lateral ventricles on cranial ultrasound  
 Broncho-pulmonary dysplasia defined as a need for supplementary oxygen to 
maintain oxygen saturation above 90% after 36 completed weeks of gestation 
 Neonatal sepsis proven on blood culture, and  
 Necrotizing enterocolitis defined as the presence of pneumatosis or 
perforation on X-ray or disease confirmed at laparotomy.  
 
Definitions for perinatal death included: (45) 
 Intrauterine fetal death (IUFD): death of a fetus while in-utero from 20 weeks of 
gestation 
 Early Neonatal death (END): a live birth where death occurs within the first seven days 
of life 
 Late Neonatal death (LND): a live birth where death occurs after 7 days  and before 28 
days of life 
 Infant death (ID): a live birth where death occurs between 28 and 364 days of life 
If intrauterine fetal death or postnatal death occurred, mothers received grievance 
counselling post-delivery by the social workers assigned to the maternity section of the 
hospital.  Genetic counselling was included in the management if a genetic, congenital or 
structural abnormality was diagnosed. 
 
Once babies were delivered, they were reviewed by the researcher on a regular basis in the 
neonatal wards to ascertain if morbidities as described above were diagnosed.  The patients’ 
files were reviewed to track their clinical progress and the neonatal registers were checked to 
determine if the babies were stepped down to another ward, discharged or had demised.   
 
The Neonatal Department’s RedCap system was searched for neonates who could not be 
traced.  This is a data-collection system that documented all neonates admitted from labour 
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ward nursery to either NICU, TICU or Ward 66 (lower risk Neonates) and included 
information regarding their progress until discharge or death.  The neonatal death record 
books were also checked for evidence of mortality in any of the study babies.  Some neonatal 
files had to be accessed using the mothers’ hospital details and a few mothers were 
contacted telephonically by the researcher to determine outcomes of their babies. 
 
5.11 DATA ANALYSIS: 
 
Categorical variables were described using frequencies and percentages.  Continuous 
variables were described using standard deviations or medians and interquartile ranges.  In 
the event of comparison of outcomes, Kai squares were used to compare categorical 
variables and the T test was used to compare continuous variables.  Data analysis was 
outsourced to Dr Allison Bentley. 
 
5.12 PERMISSION TO CONDUCT THIS RESEARCH AND ETHICS CLEARANCE: 
 
Permission to conduct research was requested from the CEO of CHBAH and obtained on 
10/3/2015.  Application to the Human Research Ethics committee (HREC) of the University of 
Witwatersrand was made in March 2015 and approval was given in May 2015.  Clearance 
certificate number 150350.  The research was approved by the Postgraduate Committee of 




All costs of travel, printing and telephones calls were borne by the researcher. 
  




A total of 60 women were recruited for the study.  One patient was excluded as she did not 
fit the inclusion criteria in terms of gestational age.  Another was excluded as the EFW was 
not in keeping with the actual birth weight and the baby no longer fitted the criteria for IUGR.  
A further 5 women were lost to follow up after their recruitment at the first ultrasound, so 
were excluded from the data analysis.  Six study participants had missing data on the final 
outcome of their babies, but were followed up until admission to the neonatal transitional 
ICU.   The data from these six participants was used to create a survival curve, but was 
excluded from the final morbidity and mortality analysis.  There were therefore 47 patients 
included in the final analysis. 
  
6.1 MATERNAL DEMOGRAPHICS: 
 
Forty seven women were included.  The mean age was 30.8 years (± 6.4).  Mean gestational 
age was 28 weeks and 2 days gestation.  Just over 29% of women had a parity of 0, 35.5% 
had a parity of 1, 22.9% a parity of 2, 6.2% a parity of 3 and 6.2% a parity of 5.  Twenty of the 
47 women reported previous pregnancy losses.  18.8% of women had a gravidity of 1, 27.1% 
had a gravidity of 2, 29.2% had a gravidity of 3, 8.3% had a gravidity of 4, 6.2% a gravidity of 
5, 8.3% a gravidity of 6, none a gravidity of 7 and 2.1% had a gravidity of 8.   
 
Booking bloods included Rhesus, HIV and RPR result.  Forty six were Rhesus positive and one 
Rhesus result was unknown.  Eleven women were HIV positive (all on antiretroviral therapy), 
35 women were HIV negative and one result was unknown.  All 47 women were RPR 
negative. 
 
In terms of previous caesarean section for delivery, 70.8% had never had a caesarean section, 
21.2% had had one and 6.4% had had 2 previous caesarean sections.  Forty five women of 
the 47 study participants denied any drug use, while one woman was a smoker and one 
woman reported marujuana use throughout the pregnancy.  The body mass index was 
calculated for 44 of the 47 women due to missing data and the mean (SD) was 31.9 (7.3) 
kg/m2 .   
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Five women had no comorbidities and in one patient, the presence of comordidity was not 
known.  Forty one women reported comorbidities, with 7 of these women having more than 
one comorbidity.  Table 1 lists the cormorbidities present in the participants.  Hypertensive 
disorders of varying severity was by far the most common comorbidity, affecting 39 (83%) of 
the 47 study participants.   
 




HELLP syndrome  3 
Antiphospholipid syndrome 7 
Systemic lupus erythematosus 1 
Renal failure 2 
Multi-fibroid uterus 1 




6.2 ULTRASOUND FINDINGS: 
 
Forty seven ultrasound findings were analysed.  The range of estimated fetal weight was 500-
1557g, with a mean estimated fetal weight of 845.2g.  Table 2 below summarises the 
estimated fetal weight centiles.   
 
Table 2: EFW Centiles 
Centile Number (n=47) Percentage 
<3rd 26 55.3 
3rd 18 38.3 
5th 1 2.1 
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10th 1 2.1 
50th 1 2.1 
 
The table demonstates that most of the study participants already had severe IUGR at the 
time of diagnosis, with 55.3% of study participants having an EFW of < 3rd centile.   
 
Four of 47 study participants had anyhydramnios, 36 of the 47 had oligohydramnios while 7 
had normal liquor volumes.  Seventy nine percent of fetuses were cephalic, while 21% were 
breech.   
 
Table 3: Doppler Abnormalities 
Doppler Abnormality Number (n=47) Percentage (%) 
AEDF only 10 21.3 
AEDF and redistribution (MCA PI 
on/below the 5th centile) 
20 42.6 
AEDF + redistribution  (MCA PI on/below 
the 5th centile) + increasing Ductus 
Venosus PI 
7 14.9 
AEDF + redistribution (MCA PI on/below 
the 5th centile) + reversal of flow in the 
Ductus Venosus PI 
3 6.3 
REDF + redistribution (MCA PI on/below 
the 5th centile) 
1 2.1 
REDF + redistribution (MCA PI on/below 




Table 3 above describes the Doppler changes found on ultrasound.  The most common 
Doppler finding was AEDF in the Umbilical artery with redistibution seen in the MCA.  The 
least commonly found change in the Dopplers was REDF in the UA with redistribution seen 
on the MCA. 
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6.3 DELIVERY INFORMATION: 
 
The average gestation at delivery was 29 weeks and 2 days for 47 study participants.  The 
range of birth weights was from 485g to 1455g with a average birth weight of 853.5g.  The 
average time from diagnosis of IUGR with abnormal Dopplers (by ultrasound) to delivery was 
6.5 days.   
 
Table 4: A comparison of estimated and actual fetal weights 
 Estimated weight Birth weight 
Lowest weight 419 485 
25% 698 742 
50% (median) 844 830 
75% 994 963 
Highest weight 1557 1455 
 
As can be seen in Table 4, the estimated weights on sonar and the actual fetal weights were 
quite similar, also keeping in mind that there was an average delay of 6.5 days from when the 
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Figure 1: Birth Weight Catergories 
 
Figure 1 demonstartes the birth weight categories for all 47 study participants.  Of 
note is that two IUFD’s and one medical TOP did not have the birth weights 
documented in the labour ward registers.  37 (78.7%) are considered extremely low 
birth weight with birth weights below one kilogram and 7 (14.9%) and considered 
very low birth weight, with weights between 1000-1499 grams. 
 
Refer to Table 5.  Thirty six of the study participants were delivered by caesarean 
section for various indications (all with live fetuses when going to theatre), while 11 
delivered by NVD.  All 11 NVD’s were inductions of labour, 9 of which were IUFD’s and 












<500g 500-999g 1000-1499g Unknown
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Table 5: Indications for caeserean sections as per patient consent forms  
Indication: Number (n=36): Percentage (%): 
Fetal Distress 17 47.2 
Severe IUGR 1 2.8 
Abnormal Dopplers 10 27.8 
Eclampsia 1 2.8 
Severe Preeclampsia 1 2.8 
HELLP Syndrome 2 5.6 
Deteriorating renal function 1 2.8 
Unknown (Consent not 




Fetal distress was the most common indication (47.2%), with abnormal Dopplers 
found to be the second most common indication, accounting for 27.8% of the 
caeserean sections performed. 
 
In the 36 patients who had live fetuses on transfer to theatre, 33 were given a 
completed course of steroids (12mg Betamethasone IMI BD; two doses) before 
delivery, 1 patient did not receive steroids (the reason was not clear) and in 2 
patients, it was not documented if steroids were given.  The Apgars and pH of the 
babies at delivery were excluded from the analysis due to large amount of missing 
data.   
 
6.4 NEONATAL ADMISSION DETAILS: 
 
Of the 36 patients who underwent caesarean section, 3 were fresh stillbirths and 
excluded from neonatal admission data.  Of 33 study participants with live-born 
fetuses, 32 were admitted to TICU (Transitional Intensive Care Unit) and 1 was 
admitted to Ward 66, which is the lower level of care ward in neonates.  Only 1 baby 
was stepped up to NICU (Neonatal ICU) from TICU and ventilated after a cardiac 
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arrest in the ward.  All other babies did not qualify for ventilation due to their low 
birth weights.   
 
Surfactant was given to 11 (n=33) babies in TICU, it was not given to 18 babies and 
was unknown in 4 babies.  CPAP (Continuous Positive Airway Pressure) ventilation was 
administered to 21 babies,  it was not given to 11 babies and was unknown in 1 baby.    
 
6.5 PERINATAL MORBIDITY AND MORTALITY: 
 
Perinatal morbidity and mortality only included 47 study participants in which the 
final outcomes were known.  The final outcome was lost for 6 babies after delivery 
during the neonatal admission, so they were excluded from further anaylsis.   
 
A survival curve was done for all 53 babies that were followed up, including the six 
that were know in TICU and then lost to further follow up: 
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Survival of Data 2:Survival proportions


















 Figure 2: Survival Curve 
 
The median survival was 218 days.  At birth (day 0), 14 (26%) babies had demised (IUFD’s, 
Medical TOP’s and FSB’s).  At day 50, only 8 babies were known to be alive.  At day 100, 2 
were known to be alive.  Of note, was that the baby that survived 218 days, was discharged 
and died two days later at home. 
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Figure 3: Summary of Outcomes 
 
As can be seen in Figure 3, more than half of the study participants demised before 
they were discharged home.  Ninteen babies survived, while 28 babies demised.  
Table 5 below  summarises the outcomes for all 47 babies. 
 
Table 5: Detailed outcomes  
Outcome Number (n=47) Percentage (%) 
Intrauterine Fetal Death 9 19.1 
Medical Termination of Pregnancy 2 4.3 
Fresh stillbirth 3 6.4 
Early neonatal Death 9 19.1 
Late Neonatal Death 3 6.4 
Infant Death 2 4.3 




Death Survival until discharge
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IUFD and END was the most common form of mortality found in the study group.   
 
Table 6 and 7 show the morbidity and mortality by weight category and weight 
centiles.  When the babies that survived were compared to those that did not, it was 
found that in the survivor group, the average gestational age was 29 weeks and 5 
days with a mean birth weight of 969g, while the group that demised had an average 
gestational age of 28 weeks and 4 days and a mean birth weight of 775.8g.  All 
mortalities were in the 3rd and <3rd centile group.  Of note in Table 6, is that 3 birth 
weights were unknown therefore it summarizes 44 of the study participants.  Sixty 
two percent of babies born below 1000g demised.  Birth weight at delivery was 
shown to be an independent risk factor for perinatal morbidity (p<0001). 
 
Table 6: Comparison between birth weight catergory and survival 
Weight Number Alive Number Demised 
<500g (n=1) 0 1 
500-999g (n=36) 14 22 











Detailed outcomes (%) 
IUFD Medical TOP FSB END LND ID HOME
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Table 7: Morbidity and Mortality by Weight Centiles 
 <3rd 3rd 5th 10th 50th 
Nil M&M 4 3 1 1 1 
Morbidity 4 5 0 0 0 
Mortality 
(n=28) 
18 10 0 0 0 
Percentage of 
mortalities 






Table 8: Morbidity and Mortality by Doppler Abnormality 
Doppler Changes Nil M & M Morbidity  Mortality Percentage of 
overall Mortalities 
(%) n=28 
AEDF only (n=10) 5 2 3 10.7 
AEDF + Redistribution 
(MCA PI on/below 5th 
centile) (n=21) 
4 6 11 39.3 
AEDF + Redistribution 
(MCA PI on/below 5th 
centile)+ Raised Ductus 
venosus PI (n=7) 
1 1 5 17.9 
AEDF + Redistribution 
(MCA PI on/below 5th 
centile) + Reversed flow 
in Ductuc Venosus (n=3) 
0 0 3 10.7 
REDF + Redistribution 
(MCA PI on/below 5th 
1 0 0 0 
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centile) (n=1) 
REDF + Redistribution 
(MCA PI on/below 5th 
centile)+ Abnormal 
Ductus Venosus Doppler 
(n=3) 
0 0 6 21.4 
 
Refer to Table 8 above, which summarises the morbidities and mortalities by Doppler 
findings.  The most common Doppler finding in the mortality group was AEDF with 
redistribution seen in the MCA, but to note is that all babies found to have REDF with 
redistribution in the MCA and an abnormality in the Ductus Venosus Doppler 
demised.  The prescence of an abnormality of the Ductus Venosus was proven to be 
statistically significant and was an independent risk factor for perinatal mortality 
(p<0.002). 
 
6.5.1 Intrauterine Fetal Death: 
There were 9 IUFD’s in the study population.  The average time from diagnosis of 
IUGR on sonar to IUFD was 10.4 days.  As above, all were delivered by NVD after 
induction of labour with oral misprostol.  Table 9 summarises the characteristics of 
the IUFD’s. 
 
Table 9: Characteristics of the IUFDs  
IUFD Gestation at 
Delivery 
Weight Centile Maternal 
Comorbidity 
Doppler Birth Weight 
(g) 




2 28w5d <3rd Nil AEDF + 
redistribution in 
MCA + Raised 
Ductus 
Unknown 
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3 26w4d 3rd Preeclampsia AEDF + 
redistribution of 
MCA + Reversed 
Ductus 
750 




5 31w4d <3rd Preeclampsia AEDF + 
redistribution in 
MCA + raised 
Ductus 
702 
6 29w3d <3rd HELLP REDF + 
redistribution in 
MCA + Raised 
Ductus 
590 




8 28w1d <3rd APLS, PTB AEDF + 
redistribution in 
MCA + raised 
Ductus 
485 





The average gestational age at diagnosis of IUFD was 29 weeks and 1 day with an average 
weight of 691.4g at delivery.  Eight nine percent were below the 3rd weight centile at a given 
gestational age.  Five babies had evidence of redistribution of the MCA, while four also had 
changes in the Ductus Venosus Doppler. 
 
54 | P a g e  
 
6.5.2 Medical Termination of Pregnancy: 
 

























Table 10 summarises the characteristics of the medical terminations of pregnancy.  Both 
babies has severe IUGR, but the first was done for maternal indications, while the second was 
for the IUGR. 
 
6.5.3 Fresh Stillbirth: 
 

















2 27w6d 3rd Severe PET REDF + 
redistribution in 
MCA + Reversed 
Ductus 
735 Severe PET 
and Severe 
IUGR 
3 27w3d 3rd Nil REDF + 786 Abnormal 
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redistribution of 




All freshstillbirths had a positive fetal heartbeat on transfer to theatre.  The median gestation 
was 27 weeksand 3 days and average weight was 786g. 
 
 
6.5.4 Early Neonatal Death: 
 

















MCA + reveresed 
Ductus 
580 Severe RDS 
2 27w3d 3rd Preeclampsia AEDF + 
redistribution in 
MCA 
816 Severe RDS 
3 28w5d <3rd Preeclampsia AEDF + 
redistribution in 









830 ELBW and 
RDS 
5 26w5d 3rd Preeclampsia REDF + 
redistribution in 
MCA + raised 
680 ELBW and 
RDS 
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Ductus 
6 26w4d 3rd Preeclampsia AEDF + 
redistribution in 
MCA 
700 ELBW and 
RDS 











9 27w2d <3rd Preeclampsia REDF + 
redistribution in 




The average gestational age in this group was 28 weeks and 2 days with an average birth 
weight of 748g.  Only one baby had documented morbidity before death, namely NEC I and 
IVH I (baby 7).  The average time from diagnosis of IUGR to delivery was 5.3 days.  The 
average time from birth to death was 2.6 days in this group.  Six babies were delivered by 
caeserean section for the abnormalities found on Doppler, two were delivered for fetal 
distress and one indication for caeserean section was not documented.  Prematurity was the 
most common documented cause of death. 
 
6.5.5 Late Neonatal Death: 
 















1 28w1d 3rd Preeclampsia AEDF 1010 Severe RDS Nil 
2 28w5d 3rd Preeclampsia AEDF + 1095 Severe RDS Sepsis 
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and APLS redistribution 
of MCA 
3 28w6d 3rd Preeclampsia AEDF + 
redistribution 
of MCA 
820 Prematurity NEC I 
 
Table 13 describes the characteristics of the 3 LND’s in the study.  The average gestational 
age at delivery in this group was 28 weeks and 4 days.  The average birth weight was 975 g.  
The average time from diagnosis of IUGR to delivery was 3.3 days and average time from 
delivery to death was 18 days.  All three babies were delivered by caesarean section for fetal 
distress. 
 
6.5.6 Infant Death: 
 















1 28w4d <3rd nil AEDF + 
redistribution 
in MCA + 
reversed 
Ductus 
785 Severe RDS Sepsis, 
NEC I, 
IVH I 
2 28w5d <3rd Preeclampsia AEDF 970 Prematurity Unknown 
 
Refer to Table 14 above.  Both babies had EFW of <3rd centile.  The average gestation at 
delivery in the infant death group was 28 weeks and 5 days, with an average bith weight of 
877.5g.  The average time taken from diagnosis of IUGR to delivery was 1 day and average 
time from birth to death was 42 days. 
 
6.5.7 Discharged Home: 
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Morbidity Age at 
Discharge 
(days) 
1 30w3d <3rd PET AEDF + 
redistribution 
oin MCA 
945 NEC I; 
IVH I 
42 
2 29w1d 3rd APLS; CHPT AEDF + 
redistribution 
in MCA 




3 28w5d 3rd PET AEDF 870 Nil 35 






5 30w1d <3rd PET AEDF + 
redistribution 
in MCA 
1055 Nil 46 
6 31w4d <3rd Eclampsia AEDF 1455 Nil 18 






8 30w2d 3rd PET AEDF + 
redistribution 
in MCA 
900 NEC I; 
Sepsis 
32 
9 28w0d 3rd Nil AEDF 785 Nil 62 








11 26w6d 3rd PET AEDF 1175 Nil 33 
12 29w3d <3rd PET AEDF + 965 Nil 53 




13 29w4d 10th PET AEDF + 
redistribution 
in MCA + 
raised Ductus 
935 Nil 34 
14 30w2d 3rd PET AEDF + 
redistribution 
in MCA 
1320 Nil 21 
15 30w1d 3rd PET REDF + 
redistribution 
of MCA 
965 Nil 36 
16 30w4d <3rd PET AEDF 1030 NEC I; 
Sepsis 
69 
17 31w1d <3rd HELLP AEDF 960 Cardiac 
arrest 
62 
18 29w0d <3rd PET AEDF + 
redistribution 
in MCA + 
raised Ductus 
775 NEC II; 
BPD 
92 
19 28w3d 5th Eclampsia AEDF + 
redistribution 
in MCA 




Table 15 summarises the characteristics of those babiess who were discharged home.  The 
average birth weight was 969.5g in this group with an average gestational age of delivery of 
29 weeks and 5 days.  Babies were delivered within 4.8 days of diagnosis of IUGR and 
discharged home after an average of 62.6 days (range of 18-216 days).  52.6% of these babies 
fulfilled the criteria for major morbidity.  One baby was discharged home but died two days 
later, so did not fit the criteria for mortality for the study.  All but one of the mothers suffered 
from a hypertensive condition. 
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7. DISCUSSION: 
Although the study population was relatively small, this study showed many results that were 
in keeping with the current literature, as well as raising topics for further studies needed to 
optimise patient management in IUGR.  In this setting, there is a high mortality rate, as well 
as a high morbidity rate in babies with IUGR that survive to be discharged home. 
 
7.1 MATERNAL DEMOGRAPHICS: 
 
Of note, was the high prevalence of hypertensive conditions found in the mothers registered 
for the study.  Fourty one of 47 women had comorbidities, with 83% of these being 
hypertensive conditions.  Hypertension has been found to have a 8-15% risk of IUGR and was 
the largest risk factor identified in our study, although it was not statistically significant as a 
predictor of morbidity or mortality in the study (p=0.1057).  In the TRUFFLE study, 
hypertensive conditions were diagnosed in 73% of study participants and in contast to this 
study, they were found to be an independent predictor of poorer outcomes in IUGR.  This 
implies that while HPT is a significant risk factor for the development of IUGR, its severity is 
not necessarily a predictor of pregnancy outcomes in IUGR in this study.  Twenty of the 47 
study participants also reported prior pregnancy losses, suggesting placental abnormalities 
may be common in the study group.   
 
7.2 ULTRASOUND FINDINGS: 
 
The average gestational age at registration into the study and diagnosis with IUGR was 28 
weeks and 2 days, with an average estimated fetal weight of 845g.  If the expected weight is 
determined for this gestation from the standard growth chart used in the Fetal medicine 
Department (see Appendix B), 1200g falls on the 50th centile while 1000g is the 3rd centile.  
This highlights the fact that babies were already severely growth restricted at the time of 
diagnosis, with 55% of study participants falling below the 3rd centile for a given gestational 
age.  One of the babies were excluded from the study after delivery as the birth weight was 
1800g at 31+4 weeks of gestation, which falls on the 50th centile.  The estimated fetal weight 
on ultrasound was 1438g, which is on the 5th centile and thus the patient initially qualified for 
the study.  This is an important factor in counselling patients in the sense that EFW on 
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ultrasound is not an exact science and may be more or less than the actual delivery weight.  
Only 10 babies had an isolated Doppler abnormality in the UA, while 78.7% (37/47) already 
had Doppler abnormalities in more than one vessel, again showing that babies registered for 
the study had severe IUGR. 
 
Majority of babies also had abnormal liquor volumes, with 40 of 47 babies being diagnosed 
with either oligohydramnios or anhydramnios.  The literature is conflicting, with guidelines 
published by ACOG stating that liquor volume is of great prognostic value in IUGR (12), where 
as the Green-top Guideline published by RCOG states that oligohydramnios is of little 
prognostic value in IUGR (23).  This study showed that oligohydramnios and anhydramnios 
was not statistically significant as an risk factor for a poorer outcome (p=0.1706). 
 
7.3 DELIVERY INFORMATION: 
 
On average, babies were delivered within 6.5 days of being registered for the study.  IUGR 
babies in the study were, in the majority of cases, delivered by caesarean section (76.6%).  
This is as per institutional protocol that all live IUGR babies known to have abnormal dopplers 
are delivered by caesarean section.  Those not delivered by caesarean, were those women 
who underwent induction of labour for medical TOP or IUFD.  Majority (17 of 36 or 47%) of 
these were for a fetal distress diagnosed on NST.  The concern is that changes in NST are 
considered late signs in IUGR and a sign of severe compromise in an IUGR fetus, meaning 
these babies are already acidemic and hypoxic at birth (11).  11 of the 17 babies delivered for 
fetal distress had poor outcomes, with 7 meeting the criteria of major morbidity (although 
then being discharged home) and 4 demised.  Twenty eight caesarean sections were 
performed for fetal indications, 5 for maternal indications and in 3 cases, the indication was 
not known. 
 
7.4 NEONATAL ADMISSIONS: 
 
After excluding the three fresh stillbirths, 32 of the 33 babies were admitted to TICU after 
delivery and one was admitted to ward 66.  The neonatal protocol at CHBAH allows for access 
to ventilation, if available at the time, to babies over 900g and to cPAP over 800g.  This meant 
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that majority of the babies born from the study did not qualify for ventilation.  Only one baby, 
of 33 babies admitted, received ventilation following a cardiac arrest in TICU and was 
stepped up to NICU. 
   
7.5 PERINATAL MORBIDITY AND MORTALITY:  
 
More than half of babies registered for the study demised (59.6%).  It was shown that babies 
that survived to discharge home tended to have higher birth weights (969g vs 775.8g) and 
were born at a later gestation (29 weeks and 2 days vs 28 weeks and 4 days).  Birth weight 
was shown to be an independent predictor of morbidity and mortality (p<000.1).  Similarly, 
the TRUFFLE Study also found that poorer outcomes were strongly asscociated with earlier 
gestations and lower weights at delivery (37).  All mortalities in this study had an EFW falling 
on the 3rd centile or below the 3rd centile, although this was not proven to be statistically 
significant (p=0.1586).  The PORTO Study showed that a weight centile <3rd was the most 
statistically significant predictor of outcomes in their study group, with all 8 mortalities found 
in that group (43). 
 
Majority of babies born were considered ELBW, with 78.7% weighing less than 1000g.  The 
survival rate in this group was 38.9% (14 of 36 babies).  Fifteen percent of babies born were 
VLBW, weighing less than 1500g and the survival rate in this group was 71.4% (5 of 7 babies). 
It is important to acknowledge the compounding factor that IUGR plays in perinatal 
outcomes of preterm fetuses.  Prematurity as an isolated factor in itself leads to a greater risk 
of perinatal morbidity and mortality.  Velaphi et al conducted a study at CHBAH looking at 
2164 very low birth weight (VLBW) babies born over a two year period and aimed to 
determine the perinatal morbidity and mortality associated with prematurity of varied weight 
categories.  In total, there were 1566 survivors and 587 mortalities.  The overall survival rate 
of babies born at less than 1500g was 71%, those born at less than 1000g was 32% and there 
were no survivors in the weight category of less than 600g.  The study highlighted that babies 
born below 1000g were not offered mechanical ventilation at CHBAH and it found that the 
odds to survival to discharge almost doubled for babies in the weight category of 1000-
1099g, when compared to the group of 900-999g.  (46) 
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The study by Velaphi is important to consider as it is in a South African setting, serving the 
same demographics as this study on IUGR and provides important information about the 
NICU outcomes in the institute where the study was conducted.  The outcomes for survival 
were in fact very similar, suggesting prematurity being the most important predictor of 
outcomes, versus intrauterine growth restriction. 
 
The most common mortalities in the study group were intrauterine fetal deaths and early 
neonatal deaths, each accounting for 19.1% of the 28 mortalities.  The overall average time 
taken from diagnosis of IUGR to delivery was 6.5 days, although speciaifcally in the IUFD 
group, the average time was longer at 10.4 days, while in the neonatal death groups it was 
shorter (END was 5.3 days, LND was 3.3 days and ID was 1 day).  These findings are in keeping 
with the GRIT study, where is was found that delaying delivery lead to a greater number of 
IUFD’s, but in the immediate delivery group, there was a higher number of neonatal deaths 
although not statistically significant (47).   
 
The mortality rate was high.  Ninteen of 47 babies with final outcomes known survived until 
discharge home, but 21.3% (10 of 19) of these babies met the criteria for major morbidity 
and 80%  then also had more than one major morbidity.  NEC was diagnosed most 
commonly, affecting 6 of 10 babies, then sepsis and bronchopulmonary dysplasia each 
affecting 5 babies and IVH was the least common morbidity diagnosed, only affecting 2 of 10 
babies.  The PORTO Trial quoted a much lower rate of morbidity, with only 1 in 20 babies 
meeting the criteria for major morbidity (43). 
 
This study showed that the finding of an abnormal Ductus Venosus Doppler 
(increased/absent/reveresed) was a statistically significant predictor of morbidity and 
mortality in IUGR babies born at CHBAH (p=0.002).  This may be as a result of changes in the 
Ductus Venosus already identifying acidotic and severley compromised fetuses, who are then 
delivered and decompensate more often than babies without changes in the Ductus 
Venosus.  Only AEDF and REDF in the UA have previously been shown to be statistically 
significant, as seen in the PORTO Trial (48) and in the study by Crimmins et al, which 
compared the Doppler findings in live versus stillborn IUGR babies (33).  
 
65 | P a g e  
 
The Ductus Venosus indicates compensatory mechanisms in the fetus whereby there is an 
increase in right ventricular afterload as blood is shunted via the DV, bypassing the liver and 
then shunted across the foramen ovale to increase left ventricular afterload.  Once there is 
an accumulation of lactic acid, this mechanism fails and there are changes seen in the a-wave 
of the DV (31).  Turan had shown that once the DV is abnormal, the baby is unlikely to survive 
longer than a week inutero and that each day delivery was delayed doubled the odds of 
stillbirth (42).   
 
Babies in this study were shown to have decreased survival once the DV was abnormal.  
Other indices have been suggested in the literature that may predate changes in the DV.  The 
aortic isthmus is the arterial connection between the placental circulation and the fetal 
cerebral circulation and its Doppler may be seen as an intermediate step to assess for fetal 
hypoxia and cardiac decompensation (49).  Figueras et al conducted an observational study in 
46 fetuses that showed that changes in the aortic isthmus Doppler occurred on average one 
week before changes in the DV (50).  Del-Rio et al showed that reversed flow in the aortic 
isthmus preceeded changes in the DV by 24-48 hours, although this was also a small study 
including 51 patients (51).  However, correlation of aortic Doppler findings with perinatal 
outcomes still requires further research.  There is insufficient literature presently to justify 






The study presented many challenges throughout the study period.   
 
The first and most major limitation was that the researcher was not onsite for the first year of 
the study period.  As per methodology and protocol, the Fetal Medicine team identified, 
recruited and consented patients but the immediate follow up of the patients by the 
researcher was not always possible.  With the majority of the deliveries occuring within 6.5 
days of recruitment, the researcher sometimes only made first contact with the patient after 
delivery, meaning some study information was gained from records retrospectively.  
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The emotional distress following the diagnosis of severe IUGR and abnormal dopplers were 
under-estimated.  Patients were overwhelmed with the guarded prognoses for their babies.  
This was worse in patients who had previous pregnancy losses.  To recruit patients at the 
point of diagnosis was part of the methodology, but more patients declined entry into the 
study than anticipated.   
 
There was poor referral to the study from other registrars and sonographers.  This meant 
that multiple cases who had sonars in antenatal clinic that may have qualified for the study 
were missed. 
 
7.6.2 Ultrasound findings: 
Due to a common trend of women presenting later in their pregnancies for antenatal care, as 
well as the poor and late referral to the Fetal Medicine Team for the study as described 
above, all the patients tended to already have severe IUGR with multiple Doppler 
abnormalities at the time of registering for the study.  There were no early dating sonars due 
to late booking and unknown last menstrual periods, so accurately dating pregnancies was 
challenging.    
 
The Fetal Medicine team also reported difficulty with using the trans-cerebellar diameter as a 
definitive measure of gestational age in advanced gestations.  The TCD was often found to be 
out of keeping with gestational age when the last menstrual period was considered or an 
early ultrasound was done.  The cerebellum was difficult to access in order to assess 
correctly, especially in cases of oligohydramnios or anhydramnios, which was found in a 
majority of study participants.   
 
As was proven, women often had higher BMI’s (31.9 kg/m2) and this compromised the 
accuracy of sonars, making dating and general assessment of fetal anatomy more difficult. 
 
7.6.3 Perinatal follow up: 
The follow up of babies became very difficult in the postnatal wards, firstly with the 
researcher being offsite and only going to CHBAH on a weekly basis. Secondly, some babies 
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were lost to follow up in the wards at various points in their admissions and due to long 
hopital stays, and poor record-keeping in the admission registers, it was often difficult to 
follow up the babies.  The registers often had the admission details, but it was not always 
accurately recorded when the babies were sent to other wards or discharged.  The system is 
still all hand-written and not computerised.   
 
The Redcap system was then accessed but only two outcomes could be found on the system 
as babies records were not updated throughout their hospital stays.  Further outcomes were 
then sourced from the Neonatal Research Unit who kindly assisted with accessing files and 
discharge summaries.  For those few that the outcomes were still not found, attempt were 
made to reach the mothers telephonically, but majority of the telephone numbers given at 
the time of registration into the study, were not longer functional or there was no response 
on multiple attempts. 
 
7.7 AREAS IDENTIFIED FOR FURTHER STUDY: 
 
Ideally, a larger study would allow comparisions between each weight centile and individual 
Doppler findings.  Also, the progression of Doppler changes could be assessed if patients had 
early ultrasounds and were identified as IUGR earlier in the pregnancy. 
 
A study analysising the NST changes in IUGR fetuses and outcomes associated with various 
changes would  also be beneficial, as NST changes could then be used to assist with timing 
delivery, especially in very preterm babies where morbidity and mortality may be decreased 
if allowed more time in utero. 
 
Delivering babies when stage 2 IUGR is diagnosed or the severity has progressed to stage 2 
may need to be considered rather than waiting until stage 3 IUGR develops.  Babies with a 
raised ductus venosus doppler may have a better outcome than those with absent or 
reversed flow. 




Intrauterine Growth Restriction is a relatively common antenatal problem and has serious 
implications in our setting at CHBAH.  It is associated with a high mortality rate of 59.6% and 
preterm delivery with the average IUGR baby at CHBAH born at 29 weeks and 2 days, with an 
average birth weight of 853.5g, which in itself was identified as a strong predictor of poor 
outcomes in these babies.  The benefit of Doppler surveillence in these pregnancies is 
evident in decreasing unecessary preterm deliveries, while allowing delivery to be timed to 
decrease that rate of IUFD.  The finding of an abnormal Ductus Venosus Doppler is a 
significant factor that predicts poorer outcomes in IUGR fetuses at CHBAH.  These findings 
can assist in counselling mothers that the prognosis for a baby born with IUGR is guarded, 
especially the lower the birth weight at the time of delivery.  It also suggests that there may 
be a place to deliver fetuses with a rising PI of the Ductus Venosus, instead of delaying 
delivery until the DV is absent or reversed.   
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APPENDIX A- Data Collection Sheet 
Study Number:                                                        . 
Background: 
Age:                            Parity:                           Gravidity:                                .              
RH:               if negative, atypical antibodies:                RPR:              Hb:         . 
RVD:              if reactive, CD4:                  Treatment:                   Duration:                 . 
Previous pregnancy losses:                   Details:                                                                                        
.                                          
                                                                                                                                         . 
Previous c/s:                                          Indications:                                                           . 
Weight:                               .  Height:                                          .   BMI:                        . 
Current medication:                                                                                                          . 
Smoking or illicit drug use:                                                                                              . 
Comorbidities:                                                                                                                 . 
Details (Grade/severity etc):                                                                                            . 
 
Ultrasound Findings: 
Gestation:                                     by:                          .      FH activity:                                   . 
BPD:                                      AC:                                           FL:                                   . 
Liquor volume:                             Presentation:                         Placenta:                       . 
General anatomy:                                                                                                             . 
Estimated fetal weight:                                                                                                     . 
Dopplers:  Umbilical artery RI:                    PI:                   waveform:                          . 
 Middle cerebral artery RI:                    PI:                waveform:                           . 
 Ductus venosus RI:                 PI:                          waveform:                             . 
What are the abnormal parameters on the ultrasound at this scan:                                   
. 
                                                                                                                                        . 
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Delivery: 
Gestation:                                       Mode:                                                                      . 
If c/s, indication:                                                                                                              . 
NST changes:                                                                                                                   . 
If <34weeks gestation, celestone given?                           Dose:                                    . 
Apgars at 1 min:                        5min:                                    10 min:                             . 
Gas at delivery done Y/N         pH                                      . 
Birth weight:                                              EFW on last u/s:                                             . 
Admission:   Y/N      Ward:                                   Indication:                                         . 
Age at discharge:                                                        . 
 
Respiratory complications:      
Intubation Y/N    Duration:                                                     .           
Cpap Y/N   Duration:                                                               .         
Surfactant Y/N 
Oxygen therapy via nasal prongs:   Y/N   Duration                          . 
 
Severe Morbidity:      
 Neonatal sepsis Y/N            Blood culture result:                                                              .   
 Bronchopumonary Dysplasia  Y/N 
NEC  Y/N     Laparotomy required  Y/N         
IVH  Y/N   and Grade                .       Cooling Y/N 
 
Death:    
IUFD  Y/N  if yes, gestation                                               . 
Postnatal death  Y/N if yes, age:                                                       . 
Cause of death:                                                                                   . 
 
Follow up scans: 
Baseline Parameters: Doppler findings: 
Gestation   RI PI Waveform 
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FH activity  Umbilical 
artery 
   
BPD  
AC  Middle 
cerebral art 
   
FL  
      
AFI  Ductus 
venosus 
   
EFW  
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APPRENDIX B:  The Estimated Fetal weight growth curve 
 
 
